Abstract: The present application relates to creamer comprising vegetable lipids, casein, maltose, phosphates, and allulose.

Abstract: A display device includes: a substrate; a display element layer disposed on the substrate, where the display element layer includes a light emitting element which emits light; a polarizing film disposed on the display element layer, where the polarizing film includes a first polarizer having a first absorption axis extending to a first direction and a first transmission axis extending to a second direction orthogonal to the first direction; and a first layer disposed on one surface of the polarizing film, where the first layer has a first phase difference. Light emitted from the display element layer has a polarizing axis, and an angle between the polarizing axis and one of the first absorption axis and the first transmission axis is in a range of about 25 degrees to about 65 degrees.

Abstract: An electronic pedal apparatus includes a pad that rectilinearly moves and rotates along a pad guide while being kept in line contact with the pad guide including a shape of an arc when a driver operates the pad, an acceleration signal or a braking signal for a vehicle is generated by operation of the single pad, and a movement direction of the pad at the time of generating the acceleration signal is different from a movement direction of the pad at the time of generating the braking signal.

Abstract: An embodiment electronic pedal apparatus includes a pedal housing and an accelerator pedal assembly and a brake pedal assembly coupled to the pedal housing and configured to move along different movement trajectories when the accelerator pedal assembly and the brake pedal assembly are operated. In an embodiment, the accelerator pedal assembly is compressed and moved upward when the accelerator pedal assembly is operated, and the brake pedal assembly is compressed and moved downward when the brake pedal assembly is operated.

Abstract: A sterilization apparatus includes a main body, and a plurality of sterilization modules. The main body defines a sterilization space for sterilization of a sterilization target. The sterilization modules are disposed on a plurality of inner surfaces of the main body surrounding the sterilization space, respectively, and deliver germicidal light to the sterilization space. In addition, the sterilization module includes a support member and a plurality of light sources. A space between adjacent light sources disposed in some regions of the support member is different from a space between adjacent light sources disposed in the other regions of the support member.

Abstract: Provided is a pharmaceutical composition for preventing or treating osteoarthritis, the pharmaceutical composition including, as an active ingredient, obtusifolin, a derivative thereof, or a pharmaceutically acceptable salt thereof. The composition according to an aspect inhibits cartilage destruction-promoting factors and alleviates inflammatory responses, thereby exhibiting significantly excellent effects for preventing or treating osteoarthritis.

Abstract: An embodiment sulfur dioxide-based inorganic electrolyte is provided in which the sulfur dioxide-based inorganic electrolyte is represented by a chemical formula M·(A1·Cl(4-x)Fx)z·ySO2. In this formula, M is a first element selected from the group consisting of Li, Na, K, Ca, and Mg, A1 is a second element selected from the group consisting of Al, Fe, Ga, and Cu, x satisfies a first equation 0?x?4, y satisfies a second equation 0?y?6, and z satisfies a third equation 1?z?2.

Abstract: A silicon-carbon complex comprising carbon-based particles and silicon-based particles, wherein the silicon-based particles are dispersed and positioned on surfaces of the carbon-based particles, the carbon-based particles have a specific surface area of 0.4 m2/g to 1.5 m2/g, and the silicon-based particles are doped with one or more elements selected from the group consisting of Mg, Li, Ca, and Al, and a negative electrode active material for lithium secondary battery comprising the same.

Abstract: A negative electrode active material as well as a method of preparing a negative electrode active material which includes preparing a silicon-based compound including SiOx, wherein 0.5<x<1.3; disposing a polymer layer including a polymer compound on the silicon-based compound; disposing a metal catalyst layer on the polymer layer; heat treating the silicon-based compound on which the polymer layer and the metal catalyst layer are disposed; and removing the metal catalyst layer, wherein the polymer compound includes any one selected from the group consisting of glucose, fructose, galactose, maltose, lactose, sucrose, a phenolic resin, a naphthalene resin, a polyvinyl alcohol resin, a urethane resin, polyimide, a furan resin, a cellulose resin, an epoxy resin, a polystyrene resin, a resorcinol-based resin, a phloroglucinol-based resin, a coal-derived pitch, a petroleum-derived pitch, a tar and a mixture of two or more thereof.

Abstract: A pouch and a secondary battery including the pouch, and a method for manufacturing the same are described. The method for manufacturing the secondary battery includes: a hole formation process of forming a degassing hole in an aluminum sheet; and a lamination process of laminating a polymer layer on the aluminum sheet to manufacture a pouch; an accommodation process of accommodating an electrode assembly in the pouch; and a sealing process of sealing an outer circumferential surface of the pouch.

Abstract: Provided are an imidazoquinoline or benzoindazolone compound or a pharmaceutically acceptable salt, hydrate, solvate, enantiomer, diastereomer, tautomer or precursor drug thereof; a use thereof for preventing and treating an inflammatory disease; and an intermediate for preparing same, where the compound is used as a substrate of NQO1 to activate the oxidation-reduction of NQO1, thus making it possible to prevent the expression and activity of inflammatory cytokines, and as such, can be used for preventing or treating diseases associated with NQO1 activity.

Abstract: A method for reinjecting an electrolyte, and a secondary battery capable of being reinjected with an electrolyte are described. The method for reinjecting an electrolyte is a method for reinjecting an electrolyte into a secondary battery in which an electrode assembly and an electrolyte are accommodated in a pouch. The pouch includes an aluminum sheet, in which a functional hole is formed, and a polymer layer stacked on the aluminum sheet. The method includes a reinjection process of injecting an additional electrolyte into the pouch through the functional hole by opening the functional hole, and a sealing process of sealing the functional hole after the reinjection process.

Abstract: Disclosed is a positive electrode including: a positive electrode current collector; and a positive electrode active material layer disposed on at least one surface of the positive electrode current collector, wherein the positive electrode active material layer has a lower layer region facing the positive electrode current collector and containing a first positive electrode active material and a first binder polymer, and an upper layer region facing the lower layer region and containing a second positive electrode active material and a second binder polymer, and the Ni content of the second positive electrode active material in the upper layer region is larger than the Ni content of the first positive electrode active material in the lower layer region. Also disclosed is a lithium secondary battery including the positive electrode.

Abstract: A battery management system according to the present disclosure includes a swelling detector including at least one sensor configured to detect a swelling status of a battery cell; and a control circuit configured to generate first time-series data of the swelling status repeatedly detected during a charging procedure included in a charge/discharge cycle of the battery cell. The control circuit is configured to determine a first change amount of the swelling status in the charging procedure from the first time-series data. The control circuit is configured to determine whether the battery cell is shorted internally based on the first change amount.

Abstract: Provided are a protein complex in which estrogen receptor 2 (-ERT2) is fused to CRISPR associated protein 9 (Cas9), and a recombinant vector carrying a gene coding the protein complex, wherein ERT2 is bonded to the N-terminus and C-terminus of nuclear localization sequence (NLS)-removed Cas9 and the complex has the advantage of translocating from the cytosol into the nucleus at a certain time point upon treatment with tamoxifen and modifying a specific DNA with the aid of guide RNA (gRNA), ultimately enabling a more elaborate DNA modification operation in a desired part at a desired time point.

Abstract: Provided is a polynucleotide in which an N-terminal region of TIF1y gene is codon-optimized, a recombinant vector including the polynucleotide, and a use thereof.

Abstract: The present invention provides an electrode assembly in which a negative electrode coated with a negative electrode active material on a surface of a negative electrode collector, a separator, and a positive electrode coated with a positive electrode active material on a surface of a positive electrode collector are repeatedly laminated, the electrode assembly comprising: monocells in which the positive electrode, the separator, the negative electrode, and the separator are laminated, wherein at least two or more monocells are laminated, wherein, in any one of the monocells, an expansion part extending lengthily to one side is formed on the separators, and the expansion part of the separator surrounds the monocells laminated to be disposed at the outermost layers to fix the laminated monocells.

Abstract: Disclosed herein is a battery case configured to receive an electrode assembly and an electrolytic solution therein, the electrode assembly including a positive electrode, a negative electrode, and a separator interposed between the positive electrode and the negative electrode, the battery case including a layer structure and a gas adsorption layer formed on the inner surface of the layer structure, the gas adsorption layer including a gas adsorption material layer configured to adsorb a reaction gas that may be generated within the battery case during abnormal functioning of the electrode assembly, and a blocking layer formed on an exposed surface of the gas adsorption material layer, the blocking layer configured to prevent the gas adsorption material layer from being exposed to an ambient gas during assembly of the battery case.

Abstract: A semipermanent menstrual pad may include: a genital area cover configured to cover a female genital area and having a storage space recessed at a center of the genital area cover to store menstrual blood, and a lid part configured to cover an upper portion of the storage space to prevent the menstrual blood introduced into the storage space from leaking to the outside, in which the lid part is coupled to or separated from the genital area cover in an attachable/detachable manner and includes a through-hole through which the menstrual blood is introduced, and a first menstrual blood leak prevention projection formed along a boundary line of the through-hole and provided at a position spaced apart from the through-hole by a preset distance to primarily prevent the leak of the menstrual blood.

Abstract: The present invention provides an electrode assembly in which a negative electrode coated with a negative electrode active material on a surface of a negative electrode collector, a separator, and a positive electrode coated with a positive electrode active material on a surface of a positive electrode collector are repeatedly laminated, the electrode assembly comprising: monocells in which the positive electrode, the separator, the negative electrode, and the separator are laminated, wherein at least two or more monocells are laminated, wherein, in any one of the monocells, an expansion part extending lengthily to one side is formed on the separators, and the expansion part of the separator surrounds the monocells laminated to be disposed at the outermost layers to fix the laminated monocells.